Basu, B., Vitfell-Pedersen, J., Moreno Garcia, V., Puglisi, M., Tjokrowidjaja, A., Shah, K., . . . Banerji, U. (2012). Creatinine Clearance Is Associated with Toxicity from Molecularly Targeted Agents in Phase I Trials. Oncology.
Chicago Style CitationBasu, B., et al. "Creatinine Clearance Is Associated With Toxicity From Molecularly Targeted Agents in Phase I Trials." Oncology 2012.
Cita MLABasu, B., et al. "Creatinine Clearance Is Associated With Toxicity From Molecularly Targeted Agents in Phase I Trials." Oncology 2012.
Atenció: Aquestes cites poden no estar 100% correctes.